SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Chrouser K, Leibovich B, Bergstralh E, Zincke H, Blute M. Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer. J Urol 2005; 174: 10710; discussion 110–1
  • 2
    Neugut AI, Ahsan H, Robinson E, Ennis RD. Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma. Cancer 1997; 79: 16004
  • 3
    Baxter NN, Tepper JE, Durham SB, Rothenberger DA, Virnig BA. Increased risk of rectal cancer after prostate radiation: a population-based study. Gastroenterology 2005; 128: 81924
  • 4
    Boorjian S, Cowan JE, Konety BR et al. Bladder cancer incidence and risk factors in men with prostate cancer: results from Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol 2007; 177: 8837; discussion 887–8
  • 5
    Singh A, Kinoshita Y, Rovito PM Jr et al. Higher than expected association of clinical prostate and bladder cancers. J Urol 2005; 173: 15269
  • 6
    Brenner DJ, Curtis RE, Hall EJ, Ron E. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 2000; 88: 398406
  • 7
    Zelefsky MJ, Yamada Y, Cohen GN et al. Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 2007; 67: 6570
  • 8
    Zelefsky MJ, Chan H, Hunt M, Yamada Y, Shippy AM, Amols H. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urol 2006; 176: 14159
  • 9
    Kaplan E, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 45781
  • 10
    Gray R. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 114154
  • 11
    Herr HW, Carver B. Point: effect of radiation-associated second malignancies on prostate cancer survival. Urology 2008; 72: 96870
  • 12
    Zelefsky MJ, Housman DM, Pei X et al. Incidence of Secondary Cancer Development After High-Dose Intensity-Modulated Radiotherapy and Image-Guided Brachytherapy for the Treatment of Localized Prostate Cancer. Int J Radiat Oncol Biol Phys 2012; 83: 9539
  • 13
    Hinnen KA, Schaapveld M, van Vulpen M et al. Prostate brachytherapy and second primary cancer risk: a competitive risk analysis. J Clin Oncol 2011; 29: 45105
  • 14
    Bhojani N, Capitanio U, Suardi N et al. The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17 845 patients. Int J Radiat Oncol Biol Phys 2010; 76: 3428
  • 15
    Huang J, Kestin LL, Ye H, Wallace M, Martinez AA, Vicini FA. Analysis of second malignancies after modern radiotherapy versus prostatectomy for localized prostate cancer. Radiother Oncol 2011; 98: 816